Current Neurology and Neuroscience Reports

, Volume 3, Issue 5, pp 373–378

The role of the N-methyl-D-aspartate receptor in Alzheimer’s disease: Therapeutic potential

Authors

  • P. Murali Doraiswamy
    • Departments of Psychiatry and Medicine, and the Center for the Study of AgingDuke University Medical Center
Article

DOI: 10.1007/s11910-003-0019-8

Cite this article as:
Doraiswamy, P.M. Curr Neurol Neurosci Rep (2003) 3: 373. doi:10.1007/s11910-003-0019-8

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder with an unknown etiology. Pathologic processes implicated in AD include β-amyloid-induced synaptic failure; tau hyperphosphorylation; inflammation; oxidative stress; abnormal neurotransmission involving acetylcholine, glutamate, norepinephrine, serotonin, and dopamine; and abnormalities in second messengers, protein kinases, and apoptosis. Although each of these pathways offers potential therapeutic targets, pharmacologic manipulation of the glutamatergic N-methyl-D-aspartate receptor pathway, alone or in combination with cholinergic therapies, is emerging as the next promising strategy for the treatment of AD and vascular dementia.

Download to read the full article text

Copyright information

© Current Science Inc 2003